Skip to content

Budesonide / Formoterol / Glycopyrronium

Published: July 27, 2026Updated: August 28, 2026

This medication combines three active ingredients—an inhaled corticosteroid and two long-acting bronchodilators—in a single inhaler. It is primarily prescribed for patients with moderate to severe chronic obstructive pulmonary disease (COPD) to reduce symptoms and prevent exacerbations. The triple therapy approach provides both anti-inflammatory and airway-widening effects.

Quick summary

A triple-combination inhaler for COPD that reduces inflammation and opens airways using three different medication types.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 28, 2026Editorial policy

Key facts at a glance

RxNorm
2387330
Generic
Budesonide / Formoterol / Glycopyrronium
Class
multi-ingredient
Brands
Breztri
Availability
rx
Lactation
unknown
Routes
—
Forms
—
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Treatment of chronic obstructive pulmonary disease (COPD) in patients who require triple therapy with an inhaled corticosteroid and two bronchodilators, particularly those with a history of exacerbations.

Budesonide reduces airway inflammation, formoterol relaxes bronchial smooth muscle by stimulating beta-2 receptors, and glycopyrronium blocks muscarinic receptors to prevent bronchoconstriction—together providing comprehensive symptom relief.

This is a maintenance medication, not a rescue inhaler; patients should always have a separate short-acting bronchodilator for acute symptoms. Rinse mouth after use to prevent oral thrush. Not recommended for acute asthma attacks. May increase risk of pneumonia in COPD patients; monitor for fever, increased cough, or breathing changes.

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 28, 2026. · Read our editorial policy